As both SFRP1 and CREB3L1 could inhibit tumor proliferation [14, 15], reduced CREB3L1 expression could not inhibit CCA proliferation, we excluded CREB3L1 and STK11 from our analysis. Here, CREB3L1 is linked to cholangiocarcinoma.